Nuvation Bio (NUVB) Gross Profit: 2024-2025

Historic Gross Profit for Nuvation Bio (NUVB) over the last 1 years, with Jun 2025 value amounting to $2.3 million.

  • Nuvation Bio's Gross Profit rose 2464.77% to $2.3 million in Q2 2025 from the same period last year, while for Jun 2025 it was $4.0 million, marking a year-over-year increase of 4393.18%. This contributed to the annual value of $795,000 for FY2024, which is N/A change from last year.
  • As of Q2 2025, Nuvation Bio's Gross Profit stood at $2.3 million, which was up 127.98% from $990,000 recorded in Q1 2025.
  • In the past 5 years, Nuvation Bio's Gross Profit registered a high of $2.3 million during Q2 2025, and its lowest value of -$788,000 during Q3 2024.
  • Over the past 2 years, Nuvation Bio's median Gross Profit value was $990,000 (recorded in 2025), while the average stood at $808,400.
  • Data for Nuvation Bio's Gross Profit shows a peak YoY surged of 2,464.77% (in 2025) over the last 5 years.
  • Quarterly analysis of 2 years shows Nuvation Bio's Gross Profit stood at $1.5 million in 2024, then skyrocketed by 2,464.77% to $2.3 million in 2025.
  • Its Gross Profit was $2.3 million in Q2 2025, compared to $990,000 in Q1 2025 and $1.5 million in Q4 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Summit Therapeutics Inc. 1,387.71B 1,387.50B -
2 BeOne Medicines Ltd. 458.68B 457.16B 1.15B
3 Vertex Pharmaceuticals Inc / Ma 102.37B 99.35B -
4 Benitec Biopharma Inc. 65.38B 65.31B -
5 Regeneron Pharmaceuticals, Inc. 60.67B 60.28B -
6 Alnylam Pharmaceuticals, Inc. 60.53B 62.66B -
7 Argenx Se 45.96B 50.00B -
8 INSMED Inc 26.50B 27.40B -
9 BioNTech SE 25.15B 17.24B -
10 Nuvation Bio Inc. 1.42B 1.38B 2.26M

Historic Data

Download Data 🔒
Date Value
Sep 30, 2025 9.77M
Sep 30, 2025 9.77M
Jun 30, 2025 2.26M
Jun 30, 2025 2.26M
Mar 31, 2025 990,000
Mar 31, 2025 990,000
Dec 31, 2024 1.50M
Dec 31, 2024 1.50M
Sep 30, 2024 -788,000
Sep 30, 2024 -788,000
Jun 30, 2024 88,000
Jun 30, 2024 88,000